Boehringer and Eli Lilly have moved closer to a heart failure indication for their SGLT2 inhibitor Jardiance, as the FDA starts a fast-track review of the drug in its first use beyond diabetes.

After years of delays and debate, 2024 was the year when several health initiatives started to move forward. And advocates ...

FDA rejects Eli Lilly's Jardiance for type 1 diabetes Review of the top 100 global drug sales in 2019 Pfizer's Tyk2 inhibitor has been approved for clinical trials in China ...

Greyhound Channel phone number AstraZeneca's Osimertinib's new indication application received FDA priority review Boehringer/Eli Lilly Jardiance significantly reduces the composite risk of ...

Boehringer Ingelheim and Eli Lilly's SGLT2 inhibitor Jardiance has been approved for chronic kidney disease in the EU - the first major market to clear the new use for the drug. Adding CKD to the ...

Here are the year’s notable fiction, poetry and nonfiction, chosen by the staff of The New York Times Book Review. The winner of this year’s National Book Award in fiction has published ...

Novels by Adam Ross, Han Kang and Nnedi Okorafor; nonfiction by Imani Perry and the “Hipster Grifter”; and more. Suggested reading from critics and editors at The New York Times. Robert Coover ...

Join former prosecutor Andy McCarthy as he delves into the legal ins and outs of the latest Washington dramas with National Review editor in chief Rich Lowry. Capital Record – your weekly ...

In ‘Mothers and Sons,’ acclaimed novelist Adam Haslett shows a family torn by past trauma and battered by the social turmoil of the present.

The GOP can deliver real results and better lives for all if they have the courage to rethink how our country taxes people. Denzel’s stamp mars August Wilson’s legacy. The Trump administration ...

Major health insurance changes coming in 2025, including Medicare Advantage shifts and commercial plan adjustments. Review coverage details now.

Cardiologists are enthusiastic about Jardiance (empagliflozin ... Give directly to The Spokesman-Review's Northwest Passages community forums series -- which helps to offset the costs of several ...